PRESCRIBING INFORMATION APO-PEN-VK

Similar documents
PENICILLIN V POTASSIUM - penicillin v potassium tablet, film coated Aurobindo Pharma Limited

Penicillin VK Official FDA information, side effects and uses.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. AZITHROMYCIN Azithromycin Tablets

PART III: PATIENT MEDICATION INFORMATION. CLINDAMYCINE-150 Pr. CLINDAMYCINE-300 (Clindamycin Hydrochloride Capsules USP) Clindamycin 150 mg and 300 mg

PRODUCT MONOGRAPH. (Spiramycin Capsules) 250 mg (750,000 I.U.) and 500 mg (1,500,000 I.U.) Antibiotic

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ERYC Erythromycin delayed release capsules USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. PIFELTRO doravirine tablets

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ERLEADA apalutamide tablets

PACKAGE INSERT. for Injection, USP. Sterile. Antibiotic

PRESCRIBING INFORMATION. Cloxacillin for Injection. Cloxacillin Powder for Solution (as cloxacillin sodium) 500mg powder/vial.

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. Pantoprazole Magnesium Enteric-Coated Tablets

1165 Creditstone Road, Unit #1 November 27, 2018 Vaughan, Ontario L4K 4N7

PRESCRIBING INFORMATION. BaciJect. Bacitracin for injection U.S.P. Powder for Solution. 50,000 Units/Vial. Antibiotic

PRESCRIBING INFORMATION Including Patient Medication Information. Colistimethate for Injection USP (colistimethate sodium)

PRESCRIBING INFORMATION. Cloxacillin Powder for Solution (as cloxacillin sodium) 500mg powder/vial. 1g powder/vial. 2g powder/vial.

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION LIPIDIL EZ. fenofibrate, NanoCrystal formulation tablets

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SANDOZ AZITHROMYCIN Azithromycin Tablets

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION. ixekizumab

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. GD-AZITHROMYCIN Azithromycin tablets

PACKAGE INSERT USP ANTIBIOTIC

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (em-plis-city)

PROCTOSEDYL. Anorectal Therapy. Version Date: 85 Enterprise Blvd., Suite 500 August 10, 2018 Markham, Ontario Canada L6G 0B

PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION DIMENHYDRINATE INJECTION USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Buscopan Hyoscine Butylbromide Injection

OSPEN 1000; OSPEN ,000,000 IU film-coated tablets; 1,500,000 IU film-coated tablet

PRESCRIBING INFORMATION

PRESCRIBING INFORMATION Including Patient Medication Information USP

Phenoxymethylpenicillin-AFT AFT Pharmaceuticals Pty. Ltd

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION ORILISSA. elagolix (as elagolix sodium) tablets

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ZITHROMAX Azithromycin tablets

IMPORTANT: PLEASE READ

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection

AMOXYCILLIN SANDOZ Amoxycillin Trihydrate capsules and suspension

PRODUCT MONOGRAPH. Pr KYTRIL. granisetron hydrochloride tablets. 1 mg granisetron as hydrochloride. Manufacture Standard

PATIENT MEDICATION INFORMATION RAVICTI TM. (glycerol phenylbutyrate) Oral Liquid

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Pentamidine Isetionate for Injection BP (pentamidine isetionate)

NEW ZEALAND DATA SHEET 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Patient Information Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg, 100 mg/12.5 mg and 100 mg/25 mg Rx only

FDA-approved Medication Guide MEDICATION GUIDE. RIBASPHERE (Rīb-ă-sphere) Tablets

PRESCRIBING INFORMATION INCLUDING PATIENT MEDICATION INFORMATION DAPSONE. Dapsone Tablets USP, 100 mg. Antibacterial Sulfone

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Palbociclib Capsules

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

PATIENT MEDICATION INFORMATION

SUMMARY OF PRODUCT CHARACTERISTICS

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

Olumiant (baricitinib) tablets

Patient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR VACCINE PART III: PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (omeprazole delayed release capsules USP)

Package Leaflet: Information for the User. Clonamox 125 mg/5 ml Powder for Oral Suspension Clonamox 250 mg/5 ml Powder for Oral Suspension

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. omeprazole delayed release capsules USP

GenRx Amoxycillin Suspension

PRODUCT MONOGRAPH. Pr TAMIFLU. oseltamivir capsule 30 mg, 45 mg and 75 mg oseltamivir (as oseltamivir phosphate)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

PATIENT MEDICATION INFORMATION. MEGACE OS Megestrol acetate Oral Suspension

AMCLAVOX DUO 500/125 & AMCLAVOX DUO FORTE 875/125 TABLETS. You may need to read it again. DUO & AMCLAVOX DUO FORTE tablets used for?

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

Ceclor CD cefaclor monohydrate sustained release tablets

READ THIS FOR SAFE AND EFECTIVE USE OF YOUR MEDICATION PATIENT MEDICATION INFORMATION. Lansoprazole delayed release capsules

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION

PRESCRIBING INFORMATION. Pr SOFRAMYCIN Nasal Spray Framycetin sulfate, gramicidin and phenylephrine hydrochloride nasal spray Antibiotic-Decongestant

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

SUMMARY OF PRODUCT CHARACTERISTICS

Patient Information SIVEXTRO (sih-vex-tro) (tedizolid phosphate) tablets

MEDICATION GUIDE XIGDUO XR (ZIG- DO- OH X- R) (dapagliflozin and metformin HCL extended-release) Tablets

Medication Guide Fluoxetine Tablets, USP

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Patient Information. VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets. (tenofovir disoproxil fumarate) oral powder

MEDICATION GUIDE LEVETIRACETAM (LEE-ve-tye-RA-se-tam) TABLETS USP 250 mg, 500 mg, 750 mg and 1000 mg Rx only

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ZEPATIER 50 mg of elbasvir and 100 mg of grazoprevir

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

Patient Information VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder

Otezla (apremilast) film coated tablets

OXEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. APO-SALVENT CFC FREE salbutamol sulphate inhalation aerosol

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%

PRESCRIBING INFORMATION. Isoniazid Tablets USP 50, 100, 300 mg. Isoniazid Oral Solution USP 50 mg/5 ml. Tuberculosis Therapy Antimycobacterial

PATIENT INFORMATION LEAFLET ZYTOMIL RANGE

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

FLUIMUKAN PLUS 600 mg effervescent tablets

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

AUGMENTIN is also used to prevent infection from major surgery.

IMPORTANT: PLEASE READ

PART III: CONSUMER INFORMATION XOLAIR (omalizumab)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SABRIL (vigabatrin)

IMPORTANT: PLEASE READ

PATIENT INFORMATION LEAFLET

Summary of Product Characteristics

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine

Transcription:

PRESCRIBING INFORMATION APO-PEN-VK Penicillin V Potassium (Potassium Phenoxymethyl Penicillin) Tablets USP 500,000 i.u. (300 mg) Antibiotic Powder for suspension USP 500,000 i.u./5 Ml (300 mg/5 ml) Powder for suspension USP 200,000 i.u./5 Ml (125 mg/5 ml) Apotex Inc. 150 Signet Drive, Toronto, Ontario M9L1T9 Date of Preparation: December 19, 2018 Control No: 216278 Page 1 of 8

PRESCRIBING INFORMATION APO-PEN-VK Penicillin V Potassium (Potassium Phenoxymethyl Penicillin) Antibiotic INDICATIONS Mild to moderately severe infections caused by penicillin V sensitive microorganisms including streptococcal pharyngitis, staphylococcal infection without bacteremia and pneumococcal infections. Therapy should be guided by bacteriologic sensitivity tests and clinical response. Severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with potassium phenoxymethyl penicillin during the acute stage. Indicated surgical procedures should be performed. The following infections will usually respond to adequate dosage of potassium phenoxymethyl penicillin: Streptococcal infections (without bacteremia): Mild to moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. Note: Streptococci in groups A, C, G, H, L, and M are very sensitive to penicillin. Other groups, including group D (enterococcus), are resistant. Pneumococcal infections: Mild to moderately severe infections of the respiratory tract. Staphylococcal infections sensitive to penicillin V: Mild infections of the skin and soft tissues. Note: Reports indicate an increasing number of strains of staphylococci resistant to penicillin V, which emphasizes the need for culture and sensitivity studies in treating suspected staphylococcal infections. Fusospirochetosis (Vincent's Gingivitis and Pharyngitis): Mild to moderately severe infections of the oropharynx usually respond to therapy with oral penicillin. Note: Necessary dental care should be accomplished in infections involving the gum tissue. Page 2 of 8

For prophylaxis following rheumatic fever and/or chorea (Prophylaxis with oral penicillin on a continuing basis has proved effective in preventing recurrences of these conditions). To prevent bacterial endocarditis in patients with congenital and/or rheumatic heart lesions before dental procedures, minor upper respiratory tract surgery or instrumentation. Prophylaxis should be instituted the day of the procedure and continued for 2 or more postoperative days. Patients with a past history of rheumatic fever who are receiving continuous antibiotic prophylaxis may harbour increased numbers of penicillin resistant organisms; use of another anti-infective agent should be considered. If penicillin is to be used in these patients during surgery, the regular rheumatic fever program should be interrupted 1 week before the procedure. At the time of surgery, penicillin may be reinstituted prophylactically. For the prevention of bacteremia following tooth extraction. To reduce the development of drug-resistant bacteria and maintain the effectiveness of APO- PEN-VK and other antibacterial drugs, APO-PEN-VK should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. CONTRAINDICATIONS Oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, 1ower intestinal tract surgery, sigmoidoscopy and childbirth; in patients with a history of penicillin or cephalosporin allergy; against beta lactamase (penicillinase) producing organisms; the active treatment of syphilis, subacute bacterial endocarditis, diptheria, gas gangrene, or other severe infections due to penicillin susceptible organisms. PRECAUTIONS Serious and occasionally fatal hypersensitivity (anaphylactoid) reactions have been reported in patients receiving penicillin therapy. Careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins and other allergens. Cross sensitivity between penicillin and cephalosporins is well documented. Effective and safe skin tests which will predict an anaphylactic reaction are not generally available. Penicillin should be used with caution in individuals with histories of allergies and/or asthma. Oral administration should not be relied on in patients with severe illness, with nausea, vomiting, gastric dilatation, cardiospasm, or intestinal hypermotility. Page 3 of 8

Occasional patients will not absorb therapeutic amounts of oral penicillin. In streptococcal infections, therapy should be given for 10 days minimum. Cultures should be taken following treatment to assure eradication of streptococci. Prolonged use of antibiotics may promote overgrowth of nonsusceptible organisms, including fungi. Should superinfection occur, take appropriate measures. Susceptibility/Resistance Development of Drug Resistant Bacteria Prescribing APO-PEN-VK in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit to the patient and risks the development of resistant organisms. ADVERSE EFFECTS All degrees of hypersensitivity including fatal anaphylaxis have been reported. The most common reactions to oral penicillin are nausea, vomiting, epigastric distress, diarrhea, and black hairy tongue. The hypersensitivity reactions are skin eruptions (maculopapular to exfoliative dermatitis), urticaria; reactions resembling serum sickness, including chills, fever, edema, and anaphylaxis. Fever and eosinophilia may frequently be the only reactions observed. Hemolytic anemia, leucopenia, thrombocytopenia, neuropathy, and nephropathy may occur. OVERDOSE Treatment: Anaphylactic shock: epinephrine 0.3 ml of 1:1000 solution given by the i.v. or i.m. route in repeated doses until relief of bronchospasm and hypotension has occurred or excessive tachycardia induced. Mild hypersensitivity reactions may respond to antihistamines. DOSAGE The dosage should be determined according to the sensitivity of the microorganisms, the severity of infection and the clinical response. The usual dosage recommendations for adults and children 12 years and over are: Streptococcal infections: Mild to moderately severe infections of the upper respiratory tract, including scarlet fever and mild erysipelas: 200,000 to 500,000 units every 6 to 8 hours for 10 days. Pneumococcal infections: Mild to moderately severe infections of the respiratory tract, including otitis media: 400,000 to 500,000 units every 6 hours until the patient has been afebrile for at least 2 days. Page 4 of 8

Staphylococcal infections: Mild infections of skin and soft tissue (culture and sensitivity tests should be performed): 400,000 to 500,000 units every 6 to 8 hours. Fusospirochetosis (Vincent's Infection) of the oropharynx: Mild to moderately severe infections: 400,000 to 500,000 units every 6 to 8 hours. Prophylaxis in the following conditions: To prevent recurrence following rheumatic fever and/or chorea: 200,000 to 250,000 units twice daily on a continuing basis. To prevent bacterial endocarditis in patients with rheumatic or congenital heart lesions who are to undergo dental or upper respiratory tract surgery or instrumentation: 500,000 units the day of the procedure, 500,000 units of i.m. aqueous penicillin G 1 hour before the procedure, and 500,000 units every 6 hours for 2 days. For children under 12 years of age, dosage is calculated on the basis of body weight. Infants and small children: 25,000 to 90,000 units (15 to 50 mg)/kg in 3 to 6 divided doses. SUPPLIEDTablets: Each white tablet contains penicillin V potassium equivalent to 500,000 i.u. (300 mg) penicillin V. Available in bottles of 100, 500 and 1,000 tablets. Powder For Suspension: After reconstitution, each 5 ml of pink, cherry flavored suspension contains penicillin V potassium equivalent to either 500,000 i.u. (300 mg) or 200,000 i.u. (125 mg) of penicillin V. Each strength is available in 60 and 100 ml bottles. Page 5 of 8

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION APO-PEN-VK Penicillin V Potassium Powder for Oral Suspension, USP Read this carefully before you start taking APO-PEN-VK and each time you get a refill. This leaflet is a summary and will not tell you everything about this drug. Talk to your healthcare professional about your medical condition and treatment and ask if there is any new information about APO-PEN-VK. What is APO-PEN-VK used for? APO-PEN-VK is used to treat infections that are caused by certain bacteria. Antibacterial drugs like APO PEN VK treat only bacterial infections. They do not treat viral infections. How does PEN-VK work? APO- PEN-VK works to: Stop growth of bacteria. Kill the bacteria. Reduce the infection in your body. What are the ingredients in APO-PEN-VK? Medicinal ingredients: Penicillin V Potassium Tablets: D& C Yellow # 10 Aluminum Lake 14-18%, Sunset Yellow Aluminum Lake 40%, Methylcellulose 15 CPS, Magnesium Stearate, Croscarmellose Sodium, Colloidal Silicon Dioxide, Hydroxypropyl Cellulose Type LF, Polyethylene Glycol 8000, Titanium Dioxide, Purified Water Oral Suspension Non-medicinal ingredients: Cherry flavour, FDC Red #40, sodium benzoate, sodium citrate anhydrous, sodium cyclamate and sucrose APO-PEN-VK comes in the following dosage forms: Tablets, 300 mg Powder for oral suspension, 125 mg/5 ml and 300 mg/5 ml Do not use APO-PEN-VK if: You have ever had an allergic reaction to penicillin, other anti-biotics or any ingredients of this medicine. To help avoid side effects and ensure proper use, talk to your healthcare professional before you take APO-PEN-VK. Talk about any health conditions or problems you may have, including if you: allergies asthma severe illness with symptoms of nausea, vomiting or stomach / gut issues pregnant, or trying to become pregnant breast-feeding or plan to breast-feed Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines. Page 6 of 8

How to take APO-PEN-VK: Although you may feel better early in treatment, APO-PEN-VK should be used exactly as directed. Misuse or overuse of PEN-VK could lead to the growth of bacteria that will not be killed by APO-PEN- VK (resistance). This means that APO-PEN-VK may not work for you in the future. Do not share your medicine. Usual dose: The recommended dose of penicillin for adults and children varies according to the infection being treated. Many things can affect the dose of medication that a person needs, such as body weight and other medications. Please follow your doctor s recommended dose. Overdose: If you think you have taken too much APO-PEN-VK, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms. Missed Dose: If you miss a dose, take it as soon as possible and continue with your regular schedule. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice. What are possible side effects from using APO-PEN-VK? These are not all the possible side effects you may feel when taking APO-PEN-VK. If you experience any side effects not listed here, contact your healthcare professional. You may experience the following side effects: Nausea Vomitting Upset stomach Diarrhea Black hairy tongue Fever Chills Serious side effects and what to do about them Talk to your healthcare professional Symptom / effect Only if In all severe cases Allergic Reaction shortness of breath, rash, itching, hives, swelling of lips, face or tongue Stop taking drug and get immediate medical help If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional. Page 7 of 8

Reporting Side Effects You can report any suspected side effects associated with the use of health products to Health Canada by: Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/healthcanada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or Calling toll-free at 1-866-234-2345. NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice. Storage: Tablets: Store at 15 o C to 30 o C. Powder for suspension: Store at room temperature 15 o C to 30 o C. Suspension: Store the oral suspension for 14 days under refrigeration. If you want more information about APO-PEN-VK: Talk to your healthcare professional Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://hc-sc.gc.ca/indexeng.php); the manufacturer s website (http://www.apotex.ca/products), or by calling 1-800-667-4708. This leaflet was prepared by Apotex Inc. Last Revised: December 19, 2018 Page 8 of 8